Back Pain News and Research

Latest Back Pain News and Research

RMC offers groundbreaking new procedure for LSS patients

More than one million people are diagnosed and treated each year in the United States for lumbar spinal stenosis (LSS), a condition that occurs from the narrowing of the spinal canal. Peter Staats, M.D., in conjunction with Riverview Medical Center, is offering LSS patients a groundbreaking new procedure, mild (minimally invasive spinal decompression) that safely and therapeutically reduces pain and improves mobility.

1 Mar 2012

New approaches may increase effectiveness of SCS for severe back pain

New approaches to electrical stimulation—using an implanted device with three columns of electrodes—may increase the effectiveness of spinal cord stimulation (SCS) for severe back pain, suggests a study in the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

28 Feb 2012

Chronic pain patients at high-risk for comorbid substance abuse benefit from 3-week program

Research presented at the American Academy of Pain Medicine's 28th Annual Meeting shows that substance use education incorporated into a cognitive behavioral rehabilitation programming is effective to improve pain and function for the chronic pain patient at high-risk for comorbid substance abuse.

27 Feb 2012

AstraZeneca launches ARIMIDEX Direct to help cancer patients

AstraZeneca today announced its first-ever direct-to-patient program offering patients with a valid prescription for ARIMIDEX or anastrozole the opportunity to have the brand ARIMIDEX delivered directly to their home by Express Scripts, a specialty pharmacy services provider, for $40 per month, including shipping.

17 Feb 2012

Acorda's fourth quarter GAAP net income increases to $12.7 million

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2011.

16 Feb 2012

Kowa announces data of LIVALO vs. Crestor on pharmacodynamics of warfarin

Kowa Pharmaceuticals America, Inc. today announced data assessing the effect of LIVALO (pitavastatin) compared with Crestor (rosuvastatin) on steady-state pharmacodynamics (PD) of warfarin by measuring international normalized ratio (INR) in healthy adult subjects.

14 Feb 2012

Children with multiple psychosomatic symptoms more likely to experience physical abuse

Children who display multiple psychosomatic symptoms, such as regular aches and pains and sleep and appetite problems, are more than twice as likely to be experiencing physical abuse at home than children who do not display symptoms, according to a study in the March edition of Acta Paediatrica.

10 Feb 2012

Early retirement due to back problems reduces long-term financial capacity

Back problems are a highly prevalent health issue, and people with the condition have a significantly greater chance of retiring early from the workforce, much more so than for any other health condition. A group of Australian researchers reports that not only does early retirement limit the immediate income available to these individuals, but it also reduces their long-term financial capacity, by reducing their ability to accumulate wealth to a significant degree.

1 Feb 2012

MRI shows elevated BMI linked to greater extent and severity of degenerative disc disease

One of the largest studies to investigate lumbar spine disc degeneration found that adults who are overweight or obese were significantly more likely to have disc degeneration than those with a normal body mass index (BMI).

30 Jan 2012

Married patients benefit from herniated spinal disc surgery

Some patient subgroups see greater improvement after surgery for herniated spinal discs relative to nonoperative outcomes—notably including married patients whose symptoms are getting worse, reports a study in the January 15, 2012, issue of Spine.

5 Jan 2012

Mazor Robotics announces purchase agreement with NSH Michigan

Mazor Robotics Ltd, the leader in innovative surgical robots and complementary products for spine surgery, announced a purchase agreement with NSH Michigan, Inc.

21 Dec 2011

Top-line results from Genzyme's teriflunomide and Rebif Phase III comparison trial on RMS

Genzyme, a Sanofi company, today reported top-line results from TENERE, a Phase III clinical trial comparing the effectiveness, safety and tolerability of once-daily oral teriflunomide to interferon beta-1a, an approved injectable therapy, in people with relapsing forms of multiple sclerosis.

20 Dec 2011

Research roundup: Insurance coverage in the Great Recession; PCIP vs. CHIP

The researchers how physicians examined claims of lower back back pain and note that part of the "rising economic cost of this epidemic is the burgeoning use of indiscriminate imaging," specifically MRIs. Researchers divided patients into two groups and "the treating physician in group 1 patients was blinded to the MRI results, while the physician for group 2 patients decided on treatment after reviewing the MRI findings."

17 Dec 2011

Most practitioners advise people with LBP to take short break from work despite guidelines

Guidelines for clinical management of patients with low back pain (LBP) encourage health care practitioners to advise staying active and returning to work. Despite this, most practitioners believe work factors can cause or exacerbate LBP, and a recommendation for a "short break from work" to allow healing is common.

15 Dec 2011

$Celgene reports final results from REVLIMID-rituximab combination phase II study for relapsed/refractory CLL$

Celgene reports final results from REVLIMID-rituximab combination phase II study for relapsed/refractory CLL

Celgene International Sàrl, a subsidiary of Celgene Corporation, (NASDAQ: CELG), announced final results from a phase II investigational study evaluating the combination of REVLIMID® (lenalidomide) and rituximab in 59 patients with relapsed or refractory chronic lymphocytic leukemia (CLL). These data were presented at the 53rd Annual Meeting of the American Society of Hematology in San Diego, CA.

14 Dec 2011

Positive data from Nektar's NKTR-181 Phase 1 clinical study for chronic pain

Nektar Therapeutics today announced positive data from a Phase 1 clinical study of NKTR-181 evaluating multiple ascending oral doses of NKTR-181 over an 8-day treatment period in healthy subjects.

14 Dec 2011

Celgene announces data from REVLIMID Phase III study on high-risk asymptomatic smoldering MM

Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that updated data evaluating continuous treatment with REVLIMID (lenalidomide) in patients with high-risk asymptomatic smoldering multiple myeloma were presented at the 53rd Annual Meeting of the American Society of Hematology.

14 Dec 2011

RHUL researchers call for more unified lower back pain guidelines

Researchers at Royal Holloway, University of London are calling for more unified guidelines about returning back pain patients to work as currently the advice can be contradictory and confusing.

14 Dec 2011

Indiscriminate expensive imaging has little clinical benefit in patients requiring epidural steroid injections

Johns Hopkins-led research suggests that routine MRI imaging does nothing to improve the treatment of patients who need injections of steroids into their spinal columns to relieve pain. Moreover, MRI plays only a small role in a doctor's decision to give these epidural steroid injections (ESIs), the most common procedure performed at pain clinics in the United States.

14 Dec 2011

Celgene reports final results from REVLIMID plus VIDAZA phase II study on higher-risk MDS

Celgene International Sàrl, a subsidiary of Celgene Corporation, today reported final results from the phase II portion of a multi-center phase I/II study evaluating combination therapy with REVLIMID (lenalidomide) and VIDAZA (azacitidine) in patients with higher-risk myelodysplastic syndromes (MDS) not previously treated with either drug.

13 Dec 2011

Back Pain News and Research

Latest Back Pain News and Research

RMC offers groundbreaking new procedure for LSS patients

New approaches may increase effectiveness of SCS for severe back pain

Chronic pain patients at high-risk for comorbid substance abuse benefit from 3-week program

AstraZeneca launches ARIMIDEX Direct to help cancer patients

Acorda's fourth quarter GAAP net income increases to $12.7 million

Kowa announces data of LIVALO vs. Crestor on pharmacodynamics of warfarin

Children with multiple psychosomatic symptoms more likely to experience physical abuse

Early retirement due to back problems reduces long-term financial capacity

MRI shows elevated BMI linked to greater extent and severity of degenerative disc disease

Married patients benefit from herniated spinal disc surgery

Mazor Robotics announces purchase agreement with NSH Michigan

Top-line results from Genzyme's teriflunomide and Rebif Phase III comparison trial on RMS

Research roundup: Insurance coverage in the Great Recession; PCIP vs. CHIP

Most practitioners advise people with LBP to take short break from work despite guidelines

Celgene reports final results from REVLIMID-rituximab combination phase II study for relapsed/refractory CLL

Positive data from Nektar's NKTR-181 Phase 1 clinical study for chronic pain

Celgene announces data from REVLIMID Phase III study on high-risk asymptomatic smoldering MM

RHUL researchers call for more unified lower back pain guidelines

Indiscriminate expensive imaging has little clinical benefit in patients requiring epidural steroid injections

Celgene reports final results from REVLIMID plus VIDAZA phase II study on higher-risk MDS

Industry Focus eBook - Pharmaceutical Manufacturing (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Back Pain News and Research

Latest Back Pain News and Research

Industry Focus eBook - Pharmaceutical Manufacturing (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in